Risk of Diabetes in Children and Adolescents Exposed to Antipsychotics: A Nationwide 12-Year Case-Control Study
- 1 September 2014
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 53 (9) , 971-979.e6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Antipsychotic Medication Use Among Children and Risk of Diabetes MellitusPediatrics, 2011
- Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in ChildrenDrug Safety, 2011
- Register-based studies of mental disordersScandinavian Journal of Public Health, 2011
- European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentEuropean Child & Adolescent Psychiatry, 2011
- Antipsychotic drugs and obesityTrends in Molecular Medicine, 2011
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysisSchizophrenia Research, 2010
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia PatientsNeuropsychopharmacology, 2010
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy ChallengesHealth Affairs, 2009
- Adolescent Obesity and Puberty: The “Perfect Storm”Annals of the New York Academy of Sciences, 2008